Search Results

Memo Therapeutics AG announces that it has successfully raised CHF 20 million as part of an extension of its Series C financing, bringing the total amount raised in the funding round to CHF 45 million.

Santhera Pharmaceuticals announces that it has entered into committed financing arrangements that, when consummated, will provide Santhera with gross funding totaling approximately CHF 69 million to drive growth, repay maturing bonds and extend cash runway through to the first half of 2026, at which point Santhera expects to be cash flow break-even.

Ikerian AG and its subsidiary, RetinAI U.S. Inc. a leading developer of software solutions for medical image and data management

Alithea Genomics, an emerging leader in the field of large-scale RNA sequencing and transcriptomics, announced the closing of a CHF 2.8 million extension to its seed financing.

RELIEF THERAPEUTICS Holding SA announced the renewal of its CHF 50 million Share Subscription Facility agreement with GEM Global Yield LLC SCS and GEM Yield Bahamas Limited.

Spineart, a global spine specialist working with surgeons to accelerate the adoption of cutting-edge technologies, has successfully raised a CHF20 million convertible financing.

Sandoz, the global leader in generic and biosimilar medicines, announced the issuance of two highly successful inaugural CHF bonds with gross proceeds of CHF 750 million.